Dec. 6, 2013
The patented CPPA technology represents a novel chemistry that serves as a versatile product development platform to improve germination and seedling development, stimulate root and shoot growth, and improve the plant's ability to withstand stress. By improving plant health throughout the season, CPPA optimizes the crop's yield potential.
The first commercially available product utilizing CPPA is designed for use as a seed treatment in 2014.
FBSciences Chief Technology Officer, Terry Hanson, attributes this broad spectrum of plant health benefits to the design. "Our a.i. is the result of years of research and development work, including our proprietary production process, to consistently develop a technology with flexible methods of use. We wanted to deliver something with multiple application methods. The seed treatment, in particular, has tremendous value due to the need to protect farmers' increasing seed investments," Hanson explains. "For this reason, bio-derived seed treatment products containing ingredients like CPPA are expected to grow at a faster pace than any other segment."
FBSciences CEO Dr. David Duncan explains that "efficiency-improving and stress management products like CPPA are expected to grow in market share by 15-20% over the next five years to meet the emerging challenges to food production. Not only are we accepting this challenge, we are committed to leading in a responsible way by innovating sustainable solutions for agriculture."
FBSciences notes,over 800 studies conducted around the world by independent researchers and universities with CPPA have validated the benefits of the new active ingredient.